» Articles » PMID: 31632194

Why Are Olfactory Ensheathing Cell Tumors So Rare?

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2019 Oct 22
PMID 31632194
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The glial cells of the primary olfactory nervous system, olfactory ensheathing cells (OECs), are unusual in that they rarely form tumors. Only 11 cases, all of which were benign, have been reported to date. In fact, the existence of OEC tumors has been debated as the tumors closely resemble schwannomas (Schwann cell tumors), and there is no definite method for distinguishing the two tumor types. OEC transplantation is a promising therapeutic approach for nervous system injuries, and the fact that OECs are not prone to tumorigenesis is therefore vital. However, why OECs are so resistant to neoplastic transformation remains unknown. The primary olfactory nervous system is a highly dynamic region which continuously undergoes regeneration and neurogenesis throughout life. OECs have key roles in this process, providing structural and neurotrophic support as well as phagocytosing the axonal debris resulting from turnover of neurons. The olfactory mucosa and underlying tissue is also frequently exposed to infectious agents, and OECs have key innate immune roles preventing microbes from invading the central nervous system. It is possible that the unique biological functions of OECs, as well as the dynamic nature of the primary olfactory nervous system, relate to the low incidence of OEC tumors. Here, we summarize the known case reports of OEC tumors, discuss the difficulties of correctly diagnosing them, and examine the possible reasons for their rare incidence. Understanding why OECs rarely form tumors may open avenues for new strategies to combat tumorigenesis in other regions of the nervous system.

Citing Articles

Epigenetic regulation and factors that influence the effect of iPSCs-derived neural stem/progenitor cells (NS/PCs) in the treatment of spinal cord injury.

Yang Y, Ma B, Chen J, Liu D, Ma J, Li B Clin Epigenetics. 2024; 16(1):30.

PMID: 38383473 PMC: 10880347. DOI: 10.1186/s13148-024-01639-5.


Designing a Clinical Trial with Olfactory Ensheathing Cell Transplantation-Based Therapy for Spinal Cord Injury: A Position Paper.

Reshamwala R, Murtaza M, Chen M, Shah M, Ekberg J, Palipana D Biomedicines. 2022; 10(12).

PMID: 36551909 PMC: 9776288. DOI: 10.3390/biomedicines10123153.


Heterogeneity and Potency of Peripheral Glial Cells in Embryonic Development and Adults.

Sinegubov A, Andreeva D, Burzak N, Vasyutina M, Murashova L, Dyachuk V Front Mol Neurosci. 2022; 15:737949.

PMID: 35401107 PMC: 8990813. DOI: 10.3389/fnmol.2022.737949.


Immunological status of the olfactory bulb in a murine model of Toll-like receptor 3-mediated upper respiratory tract inflammation.

Kagoya R, Toma-Hirano M, Yamagishi J, Matsumoto N, Kondo K, Ito K J Neuroinflammation. 2022; 19(1):13.

PMID: 35012562 PMC: 8744287. DOI: 10.1186/s12974-022-02378-1.


Delving into the recent advancements of spinal cord injury treatment: a review of recent progress.

Flack J, Sharma K, Xie J Neural Regen Res. 2021; 17(2):283-291.

PMID: 34269189 PMC: 8463999. DOI: 10.4103/1673-5374.317961.


References
1.
Farid M, Demicco E, Garcia R, Ahn L, Merola P, Cioffi A . Malignant peripheral nerve sheath tumors. Oncologist. 2014; 19(2):193-201. PMC: 3926794. DOI: 10.1634/theoncologist.2013-0328. View

2.
Redekop G, Elisevich K, Gilbert J . Fourth ventricular schwannoma. Case report. J Neurosurg. 1990; 73(5):777-81. DOI: 10.3171/jns.1990.73.5.0777. View

3.
Martini R, Bollensen E, Schachner M . Immunocytological localization of the major peripheral nervous system glycoprotein P0 and the L2/HNK-1 and L3 carbohydrate structures in developing and adult mouse sciatic nerve. Dev Biol. 1988; 129(2):330-8. DOI: 10.1016/0012-1606(88)90380-6. View

4.
Feron F, Perry C, Cochrane J, Licina P, Nowitzke A, Urquhart S . Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain. 2005; 128(Pt 12):2951-60. DOI: 10.1093/brain/awh657. View

5.
Tofaris G, Patterson P, Jessen K, Mirsky R . Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci. 2002; 22(15):6696-703. PMC: 6758146. DOI: 20026699. View